| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 6 | 0 | 0 | 6 |
| GLS protein | 5 | 0 | 0 | 5 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 3 | 0 | 0 | 3 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| IDH1 | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| geminin | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 0 | 1 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| GALC protein | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 6 | 2 | 9 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 5 | 1 | 8 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| TDP1 protein | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
| progesterone receptor | 3 | 0 | 0 | 3 |
| retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
| estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| AR protein | 2 | 0 | 0 | 2 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
| G | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Interferon beta | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
| NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 3 | 0 | 5 |
| Carbonic anhydrase 2 | 0 | 3 | 0 | 5 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 1 | 0 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |